Article Details
Retrieved on: 2024-09-25 21:30:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) - U.S. drugmaker Pfizer (NYSE:PFE) said on Wednesday it would voluntarily withdraw its therapy Oxbryta, used for the treatment of sickle ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here